Compare ResMed Inc. (RMD) vs Verizon Communications Inc (VZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ResMed Inc. vs Verizon Communications Inc — how do they compare? ResMed Inc. trades at $219.5 (market cap $31.73B), while Verizon Communications Inc trades at $49.95 (market cap $206.66B). The key difference: Verizon Communications Inc is far larger — about 6.5× ResMed Inc.'s market cap, and Verizon Communications Inc pays the higher dividend (5.69%). Which is the better fit depends on your goals.
| RMD | VZ | |
|---|---|---|
Market Cap | $31.73B | $206.66B |
Sector | Health | Media |
52-Week High | $283.28 | $51.38 |
52-Week Low | $182.82 | $38.40 |
Enterprise Value | $31.08B | $393.36B |
Dividend Yield | 1.2% | 5.69% |
Volume | — | 22,584,735 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ResMed (RMD) trades at $221.05, down 3.2% on the day, with a bearish technical signal and key support at $218. The company reported strong Q4 2026 results, beating EPS estimates at $2.95, and maintains robust profitability with a 26.94% net income margin. Revenue growth remains solid, reaching $5.15B in 2025, though weak 2027 sales guidance has pressured the stock. A dividend of $0.66 is scheduled for payment in September 2026.
Outlook is mixed: strong fundamentals and a consensus price target of $235.70 suggest upside, but bearish technicals and investor lawsuits pose near-term risks. The stock offers value with a P/E of 21.19, yet competitive and regulatory challenges require monitoring for sustained growth.
Verizon (VZ) trades at $50.41, up 0.54% today, with a bullish technical signal and strong fundamental metrics including a 15.63% ROE and 11.64% net margin. Recent earnings beats and a 5%+ dividend yield support investor confidence, while the stock trades below the consensus price target of $49.69. The company's fiber expansion deal with Corning and focus on broadband growth provide positive momentum.
Outlook remains positive with cost discipline and shareholder returns driving value, though high debt levels and competitive pressures pose risks. The stock offers income appeal with growth potential from AI infrastructure investments, but requires monitoring of execution on turnaround initiatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →About Verizon Communications Inc
Verizon Communications Inc. is an integrated telecommunications company that provides wire line voice and data services, wireless services, Internet services, and published directory information. The Company also provides network services for the federal government including business phone lines, data services, telecommunications equipment, and payphones.
Read more on VZ →
